IDH3A and acute myeloid leukemia: Isocitrate dehydrogenase, an NADP+-dependent enzyme, which decarboxylates isocitrate to α-ketoglutarate in the TCA cycle, has been found to carry heterozygous mutations in the prostate including other cancers such as acute myeloid leukaemia (AML) (64).